Invitrogen™ IL-28A Human ELISA Kit

Ref.: BL-RE-093465Manufacturer ref.: EHIL28A 96 tests
€704.00 excl. VAT

Kit ELISA sandwich Interleukin 28A (Hu IL-28A) (human): quantitative determination of Hu IL-28A in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu IL-28A.

Accession number
Q8IZJ0
Dose range
13.72-10.000 pg/ml
Sensitivity of the dosage
15 pg/ml
Calibration range
15 pg/ml to 10000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen

Kit ELISA sandwich Interleukin 28A (Hu IL-28A) (human): quantitative determination of Hu IL-28A in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu IL-28A.

Kit ELISA sandwich Interleukin 28A (Hu IL-28A) (human): quantitative determination of Hu IL-28A in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu IL-28A.

Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.

Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).

Il-28A belongs to the lambda family of l-IFN, a new family of cytokines within the IL-10 superfamily. The three members of this family are IL-29 (IFN lambda 1), IL-28A (IFN lambda 2) and IL-28B (IFN lambda 3), and are also known as III interferons. The lambdas IFN signal by a heterodimer receptor, one subunit, IL-10R2, is shared with other members of the superfamily. The second subunit, IFN lambda R1 or IL-28R alpha, is unique to IFN lambdas. Signalling occurs through the Jak/STAT pathway in the same way as type I IFN (IFN alpha/beta) and activates several of the same genes despite a low sequence homology between cytokines and receptors in both families. Both families of d的IFN have antiviral activity through the induction of antiviral protein production in target cells and the regulation of class I expression in MHC. These proteins also have anti-proliferative and anti-tumour effects, making them a possible alternative to the therapies for alpha-IFN cancer. Unlike Type I IFN, which can stimulate most cells, the response to stimulation of the lambda IFN appears to be limited to dendritic and certain tumour cells due to the limited expression of the IFN lambda R1. Another notable difference is the ability of the stimulation of the IFN lambda to drive dendritic cells to CD4+CD25+FOXP3+ regulatory T cells, suggesting a possible immunoregulatory role.

Sensitivity

Sensitivity of dosage: 15 pg/ml.

Measurement range

Dose range: 13.72-10.000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Intradose variation coefficient < 10%, interdose < 12%.

Target

Target: Human.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15425043
Specifications
Accession numberQ8IZJ0
Dose range13.72-10.000 pg/ml
Sensitivity of the dosage15 pg/ml
Calibration range15 pg/ml to 10000 pg/ml
DoseELISA solid-phase sandwich
ConjugateBiotin
Product typeKit ELISA
Protein familyOther proteins
Type of sampleSerum, Surnatant, Surnatant
SpecificityThis ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-16, IL-17, IL-18, IL-29, IL-309, IP-10, G
Sufficient for96 dosages
Target speciesHuman
For use with (application)ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)282616
Gene symbol(s)IL-28A,IL28A
Coefficient of inter-dose variation< 12 %
Coefficient of intra-dose variation< 10 %
Contents of kits96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers
Marker or dyeHRP
Quantity96 tests
Regulatory statusRUO
Research disciplinesVirology
SynonymIL-28A, IL28A
TargetHuman
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl; serum, 50 μl; supernatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EHIL28A
Country of originUnited States
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.